About this trial
Isotretinoin is a common medicine used to treat moderate to severe acne. It often causes dryness of the skin and the inside of the nose. Because a normal sense of smell depends on a healthy nasal lining, this dryness may affect how well a person can smell.
This study will examine whether isotretinoin treatment changes the sense of smell in adults with acne. Before starting isotretinoin, participants will complete a standardized smell test and two short questionnaires about nasal symptoms and quality of life: the Nasal Obstruction Symptom Evaluation (NOSE) scale and the 22-item Sino-Nasal Outcome Test (SNOT-22). After at least 4 weeks of treatment, the same smell test and questionnaires will be repeated.
By comparing results before and after treatment, the study will test the hypothesis that isotretinoin has a negative effect on olfactory function and may reduce patients' ability to smell.
Eligibility criteria
Qualifiers
Diagnosed with acne and scheduled to start oral isotretinoin as part of routine dermatology care
Willing to participate and able to give informed consent
Not currently smoking
No history of allergic rhinitis, sinusitis, or active upper respiratory infection
Disqualifiers
Younger than 18 years or older than 45 years
Current cigarette smoking
History of chronic sinonasal disease
Any condition that would prevent completing the smell test
Trial design
Treatments tested in this trial
- isotretinoin
Treatment groups
Sponsors and collaborators
Uşak University
Lead sponsor
The Scientific and Technological Research Council of Turkey
Collaborator